Form 4: CalciMedica Director Robert N. Wilson Acquires 53,333 Shares of Common Stock
SEC Form 4
Director Robert N. Wilson reports the acquisition of 53,333 shares of CalciMedica, Inc. common stock at a price of $3.75 per share on November 1, 2024.
Summary
- On November 1, 2024, Robert N. Wilson, a director of CalciMedica, Inc., acquired 53,333 shares of common stock.
- The purchase price was $3.75 per share.
- Following the transaction, Wilson directly owns 417,529 shares of CalciMedica common stock.
Sentiment
Score: 5
Explanation: The document is a neutral report of a stock transaction. It doesn't inherently convey positive or negative sentiment.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 11/01/2024 | Date of the stock transaction. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.